Read RCSystemic effects of smoking. Am J Surg148:706, 1984.
2.
Fielding JESmoking: Health effects and control: Parts 1 and 2. N Engl J Med313:491 and 555, 1985.
3.
Pearl R.Tobacco smoking and longevity. Science87:216, 1938.
4.
A Report of the Surgeon General. The health consequences of smoking: Cardiovascular disease. Rockville, Md.: US. Dept. of Health and Human Services, 1983.
5.
Miller GH, Gerstein DRThe life expectancy of nonsmoking men and women. Public Health Rep98:343, 1983.
6.
Warner KEThe economics of smoking: Dollars and sense. NY State J Med83:1273, 1983.
7.
FederalEmergency Management Agency. Fire in the United States. The National Fire Incidence ReportingSystem, 1982.
8.
Schmidt F. Germany: A bankrupt health policy toward smoking . NY State J Med83:1339, 1983.
9.
Manderlier R.Belgium fights tobacco. NY State J Med83:1342, 1983.
10.
Spotlight on Japan: A search for solutions. Tobacco Reporter109:30, 1982.
11.
Rosales VJA dilemma for the Philippines. NY State J Med83:1341, 1983.
12.
Whelan EMA smoking gun: How the tobacco industry gets away with murder. Philadelphia: George F Stickley, 1984.
13.
Femi-Pearse D.Aspects of smoking in developing countries in Africa. NY State J Med83:1310, 1983.
14.
Statistical abstracts. Washington, D.C. : Tobacco Institute, 1983.
15.
Warner KEThe federal cigarette excise tax. In Proceedings of the National Conference on Smoking and Health. New York : American Cancer Society, 1981 .
16.
The Pooling Project Research Group.Relationship of blood pressure, serum cholesterol, smoking habit, relative weight, and ECG abnormalities to incidence of majority coronary events: Final report of the Pooling Project. J Chronic Dis31:201, 1978.
17.
Keys A, ed. Smoking habits in seven countries. A multivariate analysis of death and coronary heart disease. Cambridge: Harvard University Press, 1980.
18.
Kannel WB, Gordon T, eds. The Framingham Study An epidemiological investigation of cardiovascular disease. DHEW Pub. No. (NIH) 76-1083. Washington, D.C.: U.S. Dept. of Health, Education and Welfare, 1976.
19.
Hammond EC , Horn D. Smoking and death rates: Report on 44 months of follow-up of 187,783 men. II. Death rates by cause . JAMA166:1294, 1958 .
20.
Doyle JT, Dawber TR, Kannel WB, et al. The relationship of cigarette smoking to coronary heart disease. The second report of the combined experience of the Albany, NY, and Framingham, MA, studies. JAMA190:886, 1964.
21.
Doll R., Peto R.Mortality in relation to smoking: 20 years observations on male British doctors . Br Med J2:1525, 1976.
22.
Kahn HAThe Dorn study of smoking and mortality among U.S. veterans: Report on 8½ years of observation. In Haenszel W , ed. Epidemiological approaches to the study of cancer and other chronic diseases. National Cancer Institute Monograph19. Washington, D.C.: US. Dept. of Health, Education, and Welfare, Public Health Service, NIH, 1966.
23.
Willett WC, Green A., Stampfer MJ, et al. Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med317:1303, 1987.
24.
Kuller L., Meilahn E., Ockene J.Smoking and coronary heart disease. Connor WE, Bristow JD, eds. Coronary Heart Disease: Prevention, Complications, and Treatment. Philadelphia: JB Lippincott, 1985 .
25.
Kannel WB, Shurtleff D.The Framingham Study: Cigarettes and the development of intermittent claudication . Geriatrics28:61, 1973.
26.
Hughson WG, Mann JI, Garrod A.Intermittent claudication: Prevalence and risk factors. Br Med J1:1379, 1978.
27.
Kannel WBUpdate on the role of cigarette smoking in coronary artery disease . Am Heart J101:319, 1981.
28.
Juergens JL , Barker NW, Hines EAArteriosclerosis obliterans: A review of 520 cases with special reference to pathogenic and prognostic factors. Circulation21:188, 1960.
29.
Widmer LK, Greensher A., Kannel WBOcclusion of peripheral arteries: A study of 6400 working subjects . Circulation30:836, 1964.
30.
Auerbach O. , Garfinkel L.Atherosclerosis and aneurysm of aorta in relation to smoking habits and age. Chest78:805, 1980.
31.
Whisnant JPThe decline of stroke. Stroke14:160, 1984.
32.
Abbott RD, Yin Y., Reed DM, et al. Risk of stroke in male cigarette smokers. N Engl J Med315:717, 1986.
33.
Rogot E., Murray L.Smoking and causes of death among U.S. veterans: 16 years of observation . Public Health Rep95:213, 1980.
34.
Salonen JT, Puska P., Tuomilehto J., et al. Relation of blood pressure, serum lipids, and smoking to the risk of cerebral stroke. A longitudinal study in eastern Finland. Stroke13:327, 1982.
35.
Wolf PA, D'Agostino RB, Kannel WB, et al. Cigarette smoking as a risk factor for stroke. The Framingham Study JAMA259:1025, 1988.
36.
Golditz GA, Bonita R., Stampfer MJCigarette smoking and risk of stroke in middle-aged women. N Engl J Med318:937, 1988.
37.
Pettiti DB, Wingerd J., Pellegrin F., Ramcharan S.Risk of vascular disease in women: Smoking, oral contraceptives, non-contraceptive estrogens, and other factors. JAMA242:1150, 1979 .
38.
Clagett GP , Rich NM, McDonald RT, et al. Etiologic factors for recurrent carotid artery stenosis. Surgery93:313, 1983.
39.
Hertzer NR , Martinez BD, Beyen EGRecurrent stenosis after carotid endarterectomy . Surg Gynecol Obstet149:360, 1979.
40.
Rapp JH, Quarfordt P., Krupski WC, et al. Hypercholesterolemia and early stenosis after carotid endarterectomy . Surgery101:277, 1987.
Stedman RLThe chemical composition of tobacco and tobacco smoke. Chem Rev8:153, 1968.
43.
Green CRNeutral oxygenated compounds in cigarette smoke and their possible precursors. Recent advances in tobacco science. Valhalla, N.Y.: Nazler Dana Institute for Disease Prevention, American Health Foundation Series 3:94, 1977.
44.
Heliovaara M., Karvonen MJ, Punsar S.Smoking, carbon monoxide, and atherosclerotic diseases. Br Med J1:268, 1978.
45.
Couch NPOn the arterial consequences of smoking. J Vasc Surg3:807, 1986.
46.
Thomas M.Smoking and vascular surgery. Br J Surg68:601, 1981.
47.
Turino GMEffect of carbon monoxide on the cardio-respiratory system. Carbon monoxide toxicity: Physiology and biochemistry. Circulation63:253A, 1981.
48.
Wald N., Howard S., Smith PG, et al. Association between atherosclerotic disease and carboxyhemoglobin levels in tobacco smokers. Br Med J1:761, 1973.
49.
Anderson EW , Andelman RJ, Strauch JM, et al. Effect of low-level carbon monoxide exposure on onset and duration of angina pectoris . Ann Intern Med79:46, 1973.
50.
Aronow WS, Cassidy J., Van Grow JS, et al. Effect of cigarette smoking and breathing carbon monoxide on cardiovascular hemodynamics in anginal patients. Circulation50:340, 1974.
51.
DeBias DA, Banerjee CM, Birkhead NC, et al. Effects of carbon monoxide inhalation on ventricular fibrillation: Arch Environ Health31:42, 1976.
52.
Bellet S., DeGuzman NT, Kostis JB, et al. The effect of cigarette smoke on ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction. Am Heart J83:67, 1972.
53.
Astrup P., Kjeldsen K.Model studies linking carbon monoxide and/or nicotine to arteriosclerosis and cardiovascular disease. Prev Med8:295, 1979.
54.
Hugod C., Hawkins CH, Kjeldsen K., et al. Effect of carbon monoxide exposure on aortic and coronary intimal morphology in the rabbit—A re-evaluation. Atherosclerosis30:333, 1978.
55.
Bylock A., Boyers G., Jansen I., et al. Surface ultrastructure of human arteries with special reference to the effects of smoking. Acta Pathol Microbiol Immunol Scand [A]87:56, 1979.
56.
Davies RF, Topping DL, Turner DMThe effect of intermittent carbon monoxide exposure or experimental atherosclerosis in the rabbit. Atherosclerosis24:527, 1976.
57.
Birnstingle MA, Hawkins LA, McEwan T.Experimental atherosclerosis during chronic exposure to carbon monoxide. Eur Surg Res2:92, 1970.
58.
Astrup P.Studies on carbon monoxide and nicotine. In Wynder EL, Hoffman D, Gori DB. Proceedings of the Third World Conference on smoking and health. DHEW Pub. No. (NIH) 76-221. Washington, D.C.: U.S. Dept. of Health, Education, and Welfare , 1976.
59.
Astrup P., Kjeldsen K., Wanstrup J.Enhancing influence of carbon monoxide on the development of atheromatosis in cholesterol-fed rabbits. J Atheroscler Res7:343, 1967.
60.
Crebster WS , Clarkson TB, Lofland HBCarbon monoxide aggravated atherosclerosis in the squirrel monkey. Exp Mol Pathol13:36, 1970.
61.
Siggard-Anderson J., Petersen FB, Hansen TI, et al. Plasma volume and vascular permeability during hypoxia and carbon monoxide exposure. Scand J Clin Lab Invest22 (suppl 103):39, 1968.
62.
Parving HHThe effect of hypoxia and carbon monoxide on plasma volume and capillary permeability to albumin. Scand J Clin Lab Invest30:49, 1972.
63.
Boxen I.Mechanisms of atherogenesis: Endothelial hypoxia proposed as the major initiative . Med Hypotheses18:297, 1985.
64.
Su C.Actions of nicotine and smoking on circulation. Pharmacotherapy17:129, 1982.
65.
Toda N.Regional differences in response to nicotine in isolated canine arteries . Eur J Pharmacol35:151, 1976.
66.
Starke K.Regulation of noradrenalin release by presynaptic receptor system . Rev Physiol Biochem Pharmacol77:2, 1977.
67.
Hladovec J.Endothelial injury by nicotine and its prevention . Experientia34:1585, 1978.
68.
Prerovsky I. , Hladovec J.Suppression of desquamating effect of smoking on the human endothelium by hydroxyethylrutosides. Blood Vessels16:239, 1979.
69.
Booyse FM, Osikowicz G., Quarfoot AJEffects of chronic oral consumption of nicotine on the rabbit aortic endothelium . Am J Pathol102:229, 1981.
70.
Boutet M., Bazin M., Turcotte H., et al. Effects of cigarette smoke on rat thoracic aorta. Artery7:56, 1980.
71.
Herring M., Gardner A., Glover J.Seeding human arterial prostheses with mechanically derived endothelium: The detrimental effect of smoking. J Vasc Surg1:279, 1984.
72.
Krupski WC, Olive GC, Weber CA, et al. Comparative effects of hypertension and nicotine on injury-induced myointimal thickening. Surgery102:409, 1987.
73.
Clowes AW, Clowes MMThe influence of hypertension on injury-induced myointimal thickening . Surgery88:254, 1984.
74.
Kershbaum A. , Bellet S., Dickstein ER, et al. Effect of nicotine on free fatty acids. Based on a study in the human subject and the experimental animal. Circ Res9:631, 1961.
75.
Oliver MF, Yates PAInduction of ventricular arrhythmias by elevation of arterial free fatty acids in experimental myocardial infarction. Cardiology56:359, 1972.
76.
Castelli WP , Nickerson RJ, Newell JM, et al. Serum NEFA following fat, carbohydrate ingestion and during fasting as related to intracellular lipid deposition . J Atheroscl Res6:328, 1966.
77.
Wennmalm A.Nicotine inhibits hypoxia and arachidonate-induced release of prostacyclin-like activity in rabbit hearts. Br J Pharmacol69:545, 1980.
78.
Sonnenfeld T., Wennmalm A.Inhibition by nicotine of the formation of prostacyclin-like activity in rabbit and human vascular tissue. Br J Pharmacol69:609, 1980.
79.
Effeney DJProstacyclin production by the heart: Effect of nicotine and carbon monoxide . J Vasc Surg5:237, 1987.
80.
Mustard JF, Murphy EAEffect of smoking on blood coagulation and platelet survival in man . Br Med J1:846, 1963.
81.
Kinlough-Rathbone R., Packham MA, Mustard JFVessel injury, platelet adherence and platelet survival. Arteriosclerosis3:529, 1983.
82.
Steele P., Battock D., Genton E.Effects of clofibrate and sulfinpyrazone on platelet survival time in coronary artery disease. Circulation52:473, 1975.
83.
Ritchie JL, Harker LAPlatelet and fibrinogen survival in coronary atherosclerosis: Response to medical and surgical therapy. Am J Cardiol39:595, 1977.
84.
Steele P., Battock D., Pappas G., et al. Correlation of platelet survival time with occlusion of saphenous vein aorto-coronary bypass grafts. Circulation53:685, 1976.
85.
Furster V., Chesbro JH, Frye RLPlatelet survival and the development of coronary artery disease in the young adult: Effects of cigarette smoking, strong family history and medical therapy . Circulation63:546, 1981.
86.
Wennmalm A.Effects of nicotine on cardiac prostaglandin and platelet thromboxane synthesis . Br J Pharmacol64:559, 1978.
87.
McGill HCPotential mechanism for the augmentation of atherosclerosis and atherosclerotic disease by cigarette smoking. Prev Med8:390, 1979.
88.
Eisen ME, Hammond ECThe effect of smoking on packed red cell volume, red blood cell counts, haemoglobin and platelet counts. Can Med Assoc J75:520, 1956.
89.
Smith JR, Landaw SASmoker's polycythemia. N Engl J Med298:6, 1978.
Howell RWSmoking habits and laboratory tests. Lancet2:152, 1970.
92.
Friedman GD , Siegelaub AB, Seltzer CC, et al. Smoking habits and the leukocyte count . Arch Environ Health26:137, 1973.
93.
Friedman GD , Klatsky AL, Siegelaub ABThe leukocyte count as predictor of myocardial infarction. N Engl J Med290:1275, 1974.
94.
Fisch IR, Freedman SHSmoking, oral contraceptives and obesity. Effects on white blood cell count . JAMA234:500, 1975.
95.
Ludwig P., Hoidal JRAlterations in leukocyte oxidative metabolism in cigarette smokers . Am Rev Respir Dis126:977, 1982.
96.
Ogston D., Bennett NB, Ogston CMThe influence of smoking on the plasma fibrinogen concentration. Atherosclerosis11:349, 1970.
97.
Wilhelmsen L., Svardsudd K., Kosan-Bengsten K., et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med311:501, 1984.
98.
Levenson J. , Simon AC, Cambien FA, et al. Cigarette smoking and hypertension: Factors independently associated with blood hyperviscosity and arterial rigidity . Arteriosclerosis7:572, 1987.
99.
Galea G., Davidson RJL.Haematological and haemorheological changes associated with cigarette smoking . J Clin Path38:978, 1985.
100.
Ernst E., Matrai A.Abstention from chronic cigarette smoking normalizes blood rheology . Atherosclerosis64:75, 1987.
101.
Gofman JW, Lindgreen FT, Strisower B., et al. Cigarette smoking, serum lipoproteins and coronary heart disease . Geriatrics10:349, 1955.
102.
Karvonen M. , Orma E., Keys A., et al. Cigarette smoking, serum cholesterol, blood pressure and body fatness. Lancet1:492, 1959.
103.
Dawber TR, Kannel WB, Revotskie N., et al. Same factors associated with the development of coronary heart disease. Six years follow-up experience in the Framingham Study. Am J Public Health49:1349, 1959.
104.
Blackburn H., Brozck J., Taylor HL, et al. Comparison of cardiovascular and related characteristics in habitual smokers and non-smokers . Ann NY Acad Sci90:277, 1960.
105.
Thomas CBCharacteristics of smokers compared with nonsmokers in a population of healthy young adults, including observations of family history, blood pressure, heart rate, body weight, and certain psychologic traits. Ann Intern Med53:697, 1960.
106.
Bronte-Stewart B.Cigarette smoking and ischemic heart disease . Br Med J1:379, 1961.
107.
Jenkins CD , Rosenman RH, Rosenman RH, et al. Cigarette Smoking . In relationship to coronary heart disease and related risk factors in the Western Collaborative Group Study. Circulation38:1140, 1968.
108.
Hjermann J. , Helgeland A., Holme J., et al. The intercorrelation of serum cholesterol, cigarette smoking and body weight. The Oslo Study. Acta Med Scand200:479, 1976.
109.
Andrus LH, Miller DC, Stallones RA, et al. Epidemiological study of coronary disease risk factors. 1. Study design and characteristics of individual study subjects. Am J Epidemiol87:73, 1968.
110.
Konttinin A.Cigarette smoking and serum lipids in young men. Br Med J1:1115, 1962.
111.
McDonald JC , Lidwell OM, Wright EASerum cholesterol, smoking and body build. A survey in the Royal Air Force . Br J Prev Med19:111, 1965.
112.
Higgins MW , Kjelsberg M.Characteristics of smokers and nonsmokers in Tecumseh, Michigan. II. The distribution of selected physical measurements and physiologic variables and the prevalence of certain diseases in smokers and nonsmokers. Am J Epidemiol86:60, 1967.
113.
Howell RWSmoking habits and laboratory tests. Lancet2:152, 1970.
114.
Pincherle G.Factors affecting the mean serum cholesterol . J Chron Dis24:289, 1971.
115.
Dales LG, Friedman GD, Siegelaub AB, et al. Cigarette smoking and serum chemistry tests. J Chron Dis27:293, 1974.
116.
Gordon T., Kannel WB, Dawber TR, et al. Changes associated with quitting cigarette smoking. The Framingham Study Am Heart J90:322, 1975.
117.
Gordon T., Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study Am J Med62:707, 1977.
Rossner S. , Kjellin KG, Mettinger KL, et al. Dyslipoproteinemia in patients with ischemic cerebrovascular disease. A study of stroke before the age of 55. Atherosclerosis30:199, 1978.
120.
Sitori CR, Gianfranceschi G., Gritti I., et al. Decreased high density lypoprotein cholesterol levels in male patients with transient ischemic attacks. Atherosclerosis32:205, 1979.
121.
Hulley SB, Cohen R., Widdowson G.Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention. JAMA238:2269, 1977.
122.
Goldbourt U., Medalie JHCharacteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol105:75, 1977.
123.
Arntzenius AC, van Gent CM, VanderVoort H., et al. Reduced high-density lipoprotein in women aged 40-41 using oral contraceptives. Lancet1:1221, 1978.
124.
Mjos OD, Thelle DS, Forde OH, et al. Family study of high density lipoprotein cholesterol and the relation to age and sex. Acta Med Scand201:323, 1977.
125.
Garrison RJ , Kannel WB, Feinleib M., et al. Cigarette smoking and HDL cholesterol. The Framingham offspring study. Atherosclerosis30:17, 1978.
126.
Raymond TL , Delucia AJ, Bryant LRFailure of chronic cigarette smoke exposure to alter plasma lipoproteins of stumptailed macaques (Macaca, Arctoides). Atherosclerosis41:27, 1982.
127.
Rogers WR, Bass RL, Johnson DE, et al. Atherosclerosis-related responses to cigarette smoking in a baboon. Circulation61:1188, 1980.
128.
Topping DL , Dwyer T., Weller RAPeripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants. Lancet2:1327, 1977.
Castelli WP , Doyle JT, Gordon T., et al. HDL cholesterol and other lipids in coronary heart disease. Circulation55:767, 1977.
131.
Castelli WP , Gordon T., Hjortland MC, et al. Alcohol and blood lipids. Lancet2:153, 1977.
132.
St. Leger AS, Cochrance AL, Moore F.Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine . Lancet1:1017, 1979.
133.
Hopkins PN , Williams RRIdentification and relative weight of cardiovascular risk factors. Cardiol Clin4:3, 1986.
134.
Criqui MH, Wallace RB, Heiss G., et al. Cigarette smoking and plasma HDL cholesterol. Circulation62 (suppl IV):70, 1980.
135.
Wolf PACigarettes, alcohol and stroke. N Engl J Med315:1087, 1986.
136.
Haskell WI , Camargo C., Williams PT, et al. The effect of cessation and resumption of moderate alcohol intake on serum high density lipoprotein subfractions: a controlled study. N Engl J Med310:805, 1984.
137.
Gordon T., Kannel WB, McGee D., et al. Death and coronary attacks in men after giving up cigarette smoking: A report from the Framingham Study. Lancet2:1345, 1974.
138.
Friedman GD , Pettiti DB, Bawol RD, et al. Mortality in cigarette smokers and quitters: Effect of baseline differences. N Engl J Med304:1407, 1981.
139.
Multiple risk factor intervention trial research group: Multiple risk factor intervention trial. Risk factor changes and mortality results. JAMA248:1465, 1982.
140.
Holme I.On the separation of the intervention effects of diet and antismoking advice on the incidence of major coronary events in coronary high risk men. The Oslo Study. J Oslo City Hosp32:31, 1982.
141.
Rose G., Hamilton PJS, Colwell L., et al. A randomized controlled trial of anti-smoking advice: 10 year results. J Epidemiol Community Health36:102, 1982.
142.
Trials of coronary heart disease prevention. Lancet2:803, 1976.
143.
Salonen JT , Puska P., Mustaniemi H.Changes in morbidity and mortality during comprehensive community programme to control cardiovascular diseases during 1972-1977 in North Karelia. Br Med J2:1178, 1979.
144.
Silbert S. , Zazeela H.Prognosis in arteriosclerotic peripheral vascular disease. JAMA166:1816, 1958.
145.
Juergens JL , Barker NW, Hines EAArteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors . Circulation21:188, 1960.
146.
Hughson WG , Mann JI, Tibbs DJ, et al. Intermittent claudication: Factors determining outcome. Br Med J1:1377, 1978.
147.
Quick CRG , Cotton LTThe measured effect of stopping smoking on intermittent claudication. Br J Surg69(suppl): S24, 1982.
148.
Jonason T. , Bergstrom R.Cessation of smoking in patients with intermittent claudication: Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand221:253, 1987.
149.
Myers KA, King RB, Scott DF, et al. The effect of smoking on the late patency of arterial reconstructions in the legs. Br J Surg65:267, 1978.
150.
Kozlowski L., Herman CP, Frecker RCFiltering smoker's hot air. Lancet1:699, 1980.
151.
Greenlaugh RM, Laing SP, Cole PV, et al. Smoking and arterial reconstruction . Br J Surg68:605, 1981.
152.
Wray R., DePalma RG, Hubay CHLate occlusion of aortofemoral bypass grafts. Influence of cigarette smoking . Surgery70:969, 1971.
153.
Rogot E.Smoking and general mortality among U.S. veterans, 1959-1969. Washington, D.C.: US. Dept. of Health, Education, and Welfare, PHS, NIH, National Heart and Lung Institute, 1974 .
154.
Rogers RL, Meyer JS, Judd BW, et al. Abstention from cigarette smoking improves cerebral perfusion among elderly chronic smokers. JAMA253:2970, 1985 .
155.
Smoking and health.Report of the Advisory Committee of the Surgeon General of thePublic Health Service . Public Health Service Pub. No. 1103. Washington, D.C.: U.S. Dept. of Health, Education, and Welfare, 1964.
156.
National Center for Health Statistics.Division of Health Interview Statistics. Data from the National Health Inverview Survey, May 1984.
157.
United States Department of Agriculture.Tobacco Outlook and Situation Report. March 1984.
158.
Changes in cigarette smoking practices among adults. DHEW Pub. No. [PHS] 79-1250. Vital and Health Statistics of the National Center for Health Statistics, No. 52. Washington, D.C.: U.S. Dept. of Health, Education, and Welfare, 1979.
159.
Coe RM , Cohen JDCigarette smoking among medical students . Am J Public Health70:169, 1980.
160.
A Report of the Surgeon General. The health consequences of smoking: The changing cigarette. Rockville, Md.: Dept. of Health and Human Services, 1979.
161.
Rickert WS "Less hazardous" cigarettes: Fact or fiction ? NY State J Med83:1269, 1983.
162.
Benowitz NL , Hall SM, Herning RI, et al. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med309:139, 1983.
163.
Benowitz NL , Jacob P., Kozlowski LT, et al. Influence of smoking fewer cigarettes on exposure to tar, nicotine, and carbon monoxide . N Eng J Med315:1310, 1986.
164.
Lee PN , Garfinkel L.Mortality and type of cigarette smoked. J Epidemiol Community Health35:16, 1981.
165.
Hammond EC , Garfinkel L., Seidman H., et al. "Tar" and nicotine content of cigarette smoke in relation to death rates. Environ Res12:263, 1976.
166.
Kaufman DW , Helmrich SP, Rosenberg L., et al. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med308:409, 1983.
167.
Castelli WP , Garrison RT, Dawber TR, et al. The filter cigarette and coronary heart disease: The Framingham Study. Lancet2:109, 1981.
168.
Stamler J. , Beard RR, Connor WE, et al. Primary prevention of the atherosclerotic diseases. Atherosclerosis and Epidemiology Study Groups . Circulation42:55, 1970.
169.
Orleans CTUnderstanding and promoting smoking cessation: Overview and guidelines for physician intervention. Ann Rev Med36:51, 1985.
170.
Grosz HJNicotine addiction: Treatment with medical hypnosis: Part 3. J Indiana State Med Assoc72:43, 1979.
171.
Chernick V.The brains' own morphine and cigarette smoking: The junkie in disguise. Chest83:2, 1983.
172.
Hunt HA, Bespalec DAAn evaluation of current methods of modifying smoking behavior. J Clin Psychol30:431, 1974.
173.
Health and Public Policy Committee, American College of Physicians.Methods for stopping cigarette smoking . Ann Int Med105:281, 1986.
174.
Bernstein PA , Glasgow REThe modification of smoking behavior . In Pomerleau OF, Brady JP, eds. Behavioral Medicine: Theory and Practice. Baltimore: Williams & Wilkins, 1979.
175.
Best JA, Block M.On improving compliance: Cigarette smoking. In Haynes RB, Sakett DL, eds. Compliance. Baltimore: Johns Hopkins , 1979.
176.
Pechacek TF , Danaher BGHow and why people quit smoking: A cognitive-behavioral analysis. In Kendall PC, Hollon SD, eds. Cognitive Behavioral Interventions: Theory, Research and Procedures. New York: Academic Press, 1979.
177.
Syme S., Alcalay R.Control of cigarette smoking from a social perspective. Ann Rev Public Health3:101, 1982.
178.
Warner KECigarette smoking in the 1970's: The impact of the anti-smoking campaign on consumption. Science211:729, 1981.
179.
Schwartz JL , Rider G.Review and evaluation of smoking control methods: The United States and Canada, 1969-1977. DHEW Pub. No. (CDC) 78-8369. Washington, D.C. : DHEW , 1978.
180.
Bernstein DAModification of smoking behavior: An evaluative review. Psychol Bull71:418, 1969.
181.
Ejrup B.Treatment of tobacco addiction: Experiences in tobacco withdrawal clinics . In American Cancer Society.Can we help them stop?Chicago: American Cancer Society, 1964.
182.
Feldman J.An assessment of the effectiveness of nicotine chewing gum: Unfulfilled expectations . NY State J Med85:378, 1985.
183.
Blum A.Nicotine chewing gum and the medicalization of smoking. Ann Intern Med101:121, 1984.
184.
Schneider NG, Jarvik ME, Forsythe AB, et al. Nicotine gum in smoking cessation: A placebo controlled double blind trial. Addict Behav8:253, 1983.
185.
Danaher BG , Jeffrey RW, Zimmerman R., et al. Aversive smoking using printed instructions and audiotape adjuncts. Addict Behav5:353, 1980.
186.
Lichstein KL, Stalgaitis SJTreatment of cigarette smoking in couples by reciprocal aversion. Behav Ther11:104, 1980.
187.
Delahunt J. , Curran JPEffectiveness of negative practice and self-control techniques in the reduction of smoking behavior. J Consult Clin Psychol44:1002, 1976.
188.
Lando HASuccessful treatment of smokers with a broad spectrum behavioral approach . J Consult Clin Psychol45:361, 1977.
189.
Lando HAA factorial analysis for aversion and maintenance in the elimination of smoking . Addict Behav7:143, 1982.
190.
Warner KECigarette advertising and media coverage of smoking and health. N Engl J Med312:384, 1985.
191.
Ockene JK, Ockene JSNine ways to help your patients stop smoking. Your Patient and Cancer, 1982, pp 47-61.
192.
Korsak A.Motivations in smoking cessation: Which are more effective—Positive or negative motivations? World SmokingHealth4:46, 1979.
193.
Kanzler M. , Jaffe JH, Zeidenberg P.Long and short-term effectiveness of a large scale proprietary smoking cessation program: A 4 year follow-up of SmokeEnders participants. J Clin Psychol32:661, 1976.
194.
Holroyd J.Hypnosis treatment for smoking: An evaluative review. Int J Clin Exp Hypn28:341, 1980.
195.
Hall JA, Crasilneck HBDevelopment of a hypnotic technique for treating chronic cigarette smokers . Int J Clin Exp Hypn18:283, 1970.
196.
Orue MTHypnosis in the treatment of smoking. In Steinberg J, Griffiths W, Ball K, Taylor RM , eds. Health Consequences, Education, Cessation Activities and Governmental Action. Vol. II. Proceedings of the Third World Conference on smoking and health. DHEW Pub. No. (NIH) 77-1413. Washington, D.C.: Public Health Service, 1977.
197.
Cousin M.Tobacco addiction, acupuncture, nasopuncture and auriculopuncture . Gazette Medicale de France83:1973, 1976.
198.
Fuller JASmoking withdrawal and acupuncture. Med J Aust1:28, 1982.
199.
Lamontagne Y., Annable L.Acupuncture for smokers: Effect of expectation and outcome. Am J Acupuncture7:255, 1979.
200.
Hughes GH, Hymowitz N., Ockene J., et al. The multiple risk factor intervention trial (MRFIT). V Intervention on smoking. Prev Med10:476, 1981.
201.
Malotte CK , Fielding JE, Danaher BGDescription and evaluation of the smoking cessation component of a multiple risk factor intervention program. Am J Public Health71:844, 1981.
202.
Hymowitz N. , Laquatra I., Kael S.The smoking cessation reduction program. J Med Soc NJ81:487, 1984.